EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS018-03170 
Organism
Homo sapiens 
Tissue/cell
CD19+ 
Coordinate
chr10:94462040-94463060 
SNPs
Number: 1             
IDChromosomePositionGenome Version
rs1111875chr1094462882hg19
TF binding sites/motifs
Number: 6             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
HOXA13MA0650.2chr10:94462471-94462482GTTTTATTGGC-6.14
IRF1MA0050.2chr10:94462153-94462174AGAATGAAAGTGAAAGCCATG-7.26
RUNX1MA0002.2chr10:94462464-94462475TTCTGTGGTTT+6.32
SP2MA0516.2chr10:94462214-94462231CCAAGCCCCGCACCCTC+6.07
TFAP2AMA0003.3chr10:94463035-94463046TGCCTGAGGCA-6.02
ZNF263MA0528.1chr10:94462904-94462925GGAGGTGGAAGGGAGTGAGAA+6.41
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_54334chr10:94462002-94462558Spleen
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr109446286994463052
chr109446207794462382
Number: 1             
IDChromosomeStartEnd
GH10I092702chr109446195894462557
Enhancer Sequence
GGCATGTTCC ACAAGGGACT CTGAACATAG CAGTGTGATA GCTTACTATT TGTGTCCCCA 60
GCATCCAGCA GTATGTTTGG CCTACAGTAA ACTTTTAATA AATATCGTTC TACAGAATGA 120
AAGTGAAAGC CATGTGCCCT CCCTGAAGGA GAGGAGAGCC ATTTCCCTCC CTCCCCAAGC 180
CCCGCACCCT CATTATACTT CCTATTCCTT GGCCACCAGA AACATAGCTT GCCTGGATGG 240
CTTTGGCAGC ACAGCAGAAA GCATAGTGGG CAGGGGCTGT AAGTGCTACA GAGACACTTG 300
ACAGGTGCCA ACTTGGGCCA CGGGTGAGGC GAGGACATAT TTAGGTCTGT TTAAGCCTAA 360
AAAAGCTCTA AAAGAAAATG TTCTCTTCCA TCTTTTTACC AGCATAAATT TGAAGAGGAA 420
GTGCTTCTGT GGTTTTATTG GCCATTTTTC CCTTTCAGAC TTGGCAATTT CATTCAATTT 480
CCAGTTCACA CTTCTCAATT TCAATCAAGA GTTTTATTTA AAATATATCC AGTTTACTGA 540
AAAAAAAAAT GACACTATTT GGGATGGGCT GTGATCACTA CTATTTTTAT CAGCATCATC 600
TATTCAGAAA ATGGAAGCAG GAAATCCAAA TTTTTTAAAT GATTTCTGAA AGTATTTTAT 660
GAATTGCAAA GAAGTGTAGA AGGAAGAGAA AGTGTTTACT TTACATGCTC TTTCAAAGTT 720
TCAACTTTCC TTAGCTGCTT ATGGAAACTG CATTACTACA GACTTTCCAT TAATTGTAGA 780
TTAGACCAGA CTAATTCAAT AAATGTTTAA AAAATGGACC CTGAGTGCAG GTTCAGACGT 840
CCAGAGGAAA TGACTTGATG GTACGGAGGT GGAAGGGAGT GAGAAGTTAT GATGATGTAT 900
GGTGCTGTTG ATCAGTTAAT TGAAGGTAAA ATTTTTAGCT TCACCAAGCA ATTACCTGAT 960
CTCATTAAGG TCTTTAAAAT CACCTAAGTA CCATTTGCCT GAGGCAGCTG CCCCTTGTTT 1020